This Core component of the Program Project Grant will provide administrative, secretarial, and financial services for the individual projects. Second, it will also provide a cell line repository, which will provide all of the cell lines, mycoplasma testing, serum, and serum testing to Projects 2 and 3. Third, the Core will provide statistical and pharmacokinetic modeling support for the individual projects and will construct a Web-based database that will be accessible to the individual projects and will allow immediate access to all of the data collected by the individual projects. Since there are two widely separated sites (California and New Zealand) involved in this Project, it is vital that there are formal procedures in place to ensure rapid and effective communication. This will be an important function of this Core and will be realized by monthly conference calls among all of the participants, day-long face-to-face meetings every six months with the Project Leaders and Key Investigators, at one of which the External Review Committee will attend, and a database that provides instant access to all the results. The same cell lines and tumors will be used by the two biology projects (Projects 2 and 3) at the two-sites. This Core will ensure that the cells are the same and that the same serum and culture conditions are used. The Core will also perform the serum testing and mycoplasma testing of the cell lines. Statistical analysis and pharmacokinetic modeling will be important to test the hypotheses of the Project. Dr. Daniel Bloch, a biostatistician at Stanford University, and Dr. Nicholas Holford, a pharmacokinetic modeler at the University of Auckland, will be involved in these studies. They will participate in both of the twice-yearly meetings, as well the conference calls. Finally, in order to ensure comprehensive and instantaneous access to all of the data from the Project, we will construct a Web-enabled SAS database into which all the results will be entered and which will be accessible to all involved in the project.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Program Projects (P01)
Project #
1P01CA082566-01A1
Application #
6404072
Study Section
Subcommittee E - Prevention &Control (NCI)
Project Start
2000-04-25
Project End
2003-03-31
Budget Start
Budget End
Support Year
1
Fiscal Year
2000
Total Cost
Indirect Cost
Name
Stanford University
Department
Type
DUNS #
800771545
City
Stanford
State
CA
Country
United States
Zip Code
94305
Brown, Martin; Bernhard, Eric; Mitchel, James et al. (2016) Fractionated Radiation for Newly Diagnosed Supratentorial Glioblastoma Multiforme: In Regard to Brachman et al. Int J Radiat Oncol Biol Phys 94:210-211
Bonnet, Muriel; Flanagan, Jack U; Chan, Denise A et al. (2014) Identifying novel targets in renal cell carcinoma: design and synthesis of affinity chromatography reagents. Bioorg Med Chem 22:711-20
Chan, Denise A; Sutphin, Patrick D; Nguyen, Phuong et al. (2011) Targeting GLUT1 and the Warburg effect in renal cell carcinoma by chemical synthetic lethality. Sci Transl Med 3:94ra70
Bonnet, Muriel; Flanagan, Jack U; Chan, Denise A et al. (2011) SAR studies of 4-pyridyl heterocyclic anilines that selectively induce autophagic cell death in von Hippel-Lindau-deficient renal cell carcinoma cells. Bioorg Med Chem 19:3347-56
Brown, Martin (2010) Henry S. Kaplan Distinguished Scientist Award Lecture 2007. The remarkable yin and yang of tumour hypoxia. Int J Radiat Biol 86:907-17
Hicks, Kevin O; Siim, Bronwyn G; Jaiswal, Jagdish K et al. (2010) Pharmacokinetic/pharmacodynamic modeling identifies SN30000 and SN29751 as tirapazamine analogues with improved tissue penetration and hypoxic cell killing in tumors. Clin Cancer Res 16:4946-57
Hay, Michael P; Turcotte, Sandra; Flanagan, Jack U et al. (2010) 4-Pyridylanilinothiazoles that selectively target von Hippel-Lindau deficient renal cell carcinoma cells by inducing autophagic cell death. J Med Chem 53:787-97
Turcotte, Sandra; Giaccia, Amato J (2010) Targeting cancer cells through autophagy for anticancer therapy. Curr Opin Cell Biol 22:246-51
Shinde, Sujata S; Maroz, Andrej; Hay, Michael P et al. (2009) One-electron reduction potential of the neutral guanyl radical in the GC base pair of duplex DNA. J Am Chem Soc 131:5203-7
Turcotte, Sandra; Sutphin, Patrick D; Giaccia, Amato J (2008) Targeted therapy for the loss of von Hippel-Lindau in renal cell carcinoma: a novel molecule that induces autophagic cell death. Autophagy 4:944-6

Showing the most recent 10 out of 41 publications